Low-Dose Apixaban Best for Long-Term Use in Cancer

Just as effective as the high dose, low-dose apixaban prevents long-term recurrent venous thromboembolism in patients with cancer, and lowered bleeding rates, in API-CAT.
Medscape Medical News

source https://www.medscape.com/viewarticle/low-dose-apixaban-best-long-term-use-cancer-2025a10007l1?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?